New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2013
13:25 EDTMDCO, MDCO, MDCOLeerink's biotech analysts hold an analyst/industry conference call
Biotech Analyst Schwartz, along with MEDACorp Specialist Cahrles Whitcomb, MD, discuss the prospects for The Medicines Co's Cangrelor in Percutaneous Coronary Intervention (PCI)/Acute Coronary Syndrome (ACS) on an Analyst/Industry conference call to be held on February 7 at 2 pm.
News For MDCO From The Last 14 Days
Check below for free stories on MDCO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 23, 2014
07:05 EDTMDCOThe Medicines Co. reports Q2 adjusted EPS 31c, may not compare to consensus (2c)
Reports Q2 revenue $183.8M, consensus $183.75M. Reports Q2 unadjusted net loss of (8c).

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use